Bicycle Therapeutics (BCYC) Non-Current Debt (2020 - 2024)
Historic Non-Current Debt for Bicycle Therapeutics (BCYC) over the last 5 years, with Q2 2024 value amounting to $8.5 million.
- Bicycle Therapeutics' Non-Current Debt fell 7212.66% to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year decrease of 7212.66%. This contributed to the annual value of $30.7 million for FY2023, which is 126.34% up from last year.
- Bicycle Therapeutics' Non-Current Debt amounted to $8.5 million in Q2 2024, which was down 7212.66% from $30.8 million recorded in Q1 2024.
- Bicycle Therapeutics' 5-year Non-Current Debt high stood at $30.8 million for Q1 2024, and its period low was $8.5 million during Q2 2024.
- Moreover, its 5-year median value for Non-Current Debt was $30.1 million (2022), whereas its average is $26.9 million.
- In the last 5 years, Bicycle Therapeutics' Non-Current Debt skyrocketed by 10623.14% in 2021 and then plummeted by 7212.66% in 2024.
- Over the past 5 years, Bicycle Therapeutics' Non-Current Debt (Quarter) stood at $14.5 million in 2020, then surged by 105.95% to $29.9 million in 2021, then grew by 1.48% to $30.3 million in 2022, then grew by 1.26% to $30.7 million in 2023, then tumbled by 72.29% to $8.5 million in 2024.
- Its Non-Current Debt was $8.5 million in Q2 2024, compared to $30.8 million in Q1 2024 and $30.7 million in Q4 2023.